AEVI GENOMIC Revenue, Profits - GNMX Annual Income Statement

Add to My Stocks
$1.27 $0.08 (5.93%) GNMX stock closing price Sep 21, 2018 (Closing)

GNMX stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the AEVI GENOMIC stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the GNMX stock is bound to reflect the impact of the YOY decline of 0. The AEVI GENOMIC profit and loss statement for 2017 shows a net profit of $-34.71M. Profits for last year was $-41.9M. Apart from this an investor should also check AEVI GENOMIC assets and AEVI GENOMIC free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
AEVI GENOMIC Revenues or Net Sales
Cost Of Goods Sold (COGS)-------
Research & Development Expense25.17M28.35M23.61M8.25M7.29M5.43M5.05M
Selling General & Admin Expense9.52M13.52M12.95M10.68M10.52M7.19M4.92M
Income Before Depreciation Depletion Amortization-34.7M-41.87M-36.56M-18.93M-17.81M-12.62M-9.97M
Depreciation Depletion Amortization-------
Non Operating Income-0.01M-0.01M-1.4M---2.42M1.88M
Interest Expense-------
AEVI GENOMIC Pretax Income
Provision for Income Taxes-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-34.71M-41.9M-37.99M-18.43M-17.12M-15.07M-8.09M
Extraordinary Items & Discontinued Operations-------
AEVI GENOMIC Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS41.68M35.16M25.08M19.29M17.68M11.02M8.45M
Average Shares used to compute Basic EPS41.68M35.16M25.02M19.25M17.63M11.02M8.45M
Income Before Nonrecurring Items-34.71M-41.9M-29.82M-18.43M-17.13M-15.07M-8.1M
Income from Nonrecurring Items---8.17M----
AEVI GENOMIC Earnings Per Share Basic Net
AEVI GENOMIC Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.83-1.19-1.22-1.00-1.06-1.37-0.96
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

AEVI GENOMIC stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our AEVI GENOMIC revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-34.71M for AEVI GENOMIC for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The GNMX financials along with AEVI GENOMIC historical stock prices provide a lot of details about the firm.

AEVI GENOMIC Income Statement - Key Financial Ratios